German Christopher Paul's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Jul 11, 2025
- Accession no.
- 0001104659-25-067428
- Filed
- Jul 11, 2025
- Trade date
- Jul 9, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $308.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| German Christopher PaulCIK 0001260835 | Officer (Corporate Controller & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | Common Stock | MOption exerciseAcquired | +2,000 | $17.97 | +$35,940 | 3,889 | Direct | |
| Jul 9, 2025 | Common Stock | MOption exerciseAcquired | +850 | $49.23 | +$41,845.5 | 4,739 | Direct | |
| Jul 9, 2025 | Common Stock | SSaleDisposed | −1,967 | $76.75 | −$150,967.25 | 2,772 | Direct | |
| Jul 9, 2025 | Common Stock | SSaleDisposed | −1,850 | $85.00 | −$157,250 | 922 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 6,231 | Direct | |
| Jul 9, 2025 | Common Stock | MOption exerciseDisposed | −850 | $0.00 | $0 | 4,550 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.